Targeted antitumoral dehydrocrotonin nanoparticles with L-ascorbic acid 6-stearate

Journal of Pharmaceutical Sciences

Volumn 98, Issue 12, 2009, Pages 4796-4807

  Frungillo, Lucas ^a   Martins, Dorival ^a   Teixeira, Sérgio ^a   Anazetti, Maristela Conti ^a   Melo, Patrícia Da Silva ^b   Durán, Nelson ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b Faculdades Integradas Metropolinas de Campinas METROCAMP   (Brazil)

Author keywords

Cancer chemotherapy; Cell culture; Drug effects; Nanoparticles; Targeted drug delivery

Indexed keywords

ANTINEOPLASTIC AGENT; ASCORBIC ACID 6 STEARATE; ASCORBIC ACID DERIVATIVE; CASPASE 8; CASPASE 9; DEHYDROCROTONIN NANOPARTICLE; TETRAZOLIUM; TRYPAN BLUE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL DEATH; CELL STRAIN HL 60; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG SCREENING; DRUG SOLUBILITY; DRUG SYNTHESIS; DRUG UPTAKE; ENZYME ACTIVATION; ENZYME ACTIVITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; PARTICLE SIZE; THIN LAYER CHROMATOGRAPHY; ULTRAVIOLET SPECTROSCOPY; ZETA POTENTIAL;

EID: 71649109530     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.21760     Document Type: Article

References (39)

1. Ziegler DS, Kung AL. 2008. Therapeutic targeting of apoptosis pathways in cancer. Curr Opin Oncol 20:97-103.
2. World Healthy Organization, in: http://www.who.int; last access: 20/02/2008.
3. Sofou S. 2007. Surface-active liposomes for targeted cancer therapy. Nanomedicine 2:711-724. (Pubitemid 350268249)
4. Castro MA, Pozo M, Cortes C, Garcia MDA, Concha II, Nualart F. 2007. Intracellular ascorbic acid inhibits transport of glucose by neurons, but not by astrocytes. J Neurochem 102:773-782. (Pubitemid 47057307)
5. Savona M, Talpaz M. 2008. Getting to the stem chronic myeloid leukaemia. Nature Rev Cancer 8:341-350. (Pubitemid 351589698)
6. McNulty AL, Stabler TV, Vail TP, McDaniel GE, Kraus VB. 2005. Dehydroascorbate transport in human chondrocytes in regulated by hypoxia and is a physiologically relevant source of ascorbic acid in the joint. Arthritis Rheum 52:2676-2685.
7. Agus DB, Vera JC, Golde DW. 1999. Stromal cell oxidation: A mechanism by which tumors obtain vitamin C. Cancer Res 18:4555-4558.
8. Marcato PD, Durán N. 2008. New aspects of nanopharmaceutical delivery systems. J Nanosci Nanotechnol 8:1-4.
9. Durán N, Marcato PD, Buffo CM, de Azevedo MM, Esposito E. 2007. Poly (epsilon-caprolactone)/propolis extract: Microencapsulation and antibacterial activity evaluation. Pharmazie 62:287-290. (Pubitemid 46596374)
10. Lee AL, Wang Y, Ye WH, Yoon HS, Chan SY, Yang YY. 2008. Efficient intracellular delivery of functional proteins using cationic polymer core/shell nanoparticles. Biomaterials 29:224-232.
11. Jain KK. 2008. Recent advances in nanoocology. Technol Cancer Res Treat 7:1-13.
12. Har-el YE, Kato Y. 2007. Intracellular delivery of nanocarriers for cancer therapy. Curr Nanosci 3:329-338. (Pubitemid 350142041)
13. Arruebo M, Fernández-Pacheco R, Ibarra MR, Santamaría J. 2007. Magnetic naoparticles for drug delivery. Nanotoday 2:22-32.
14. Durán JDG, Arias JL, Gallardo V, Delgado AV. 2008. Magnetic colloids as drug vehicles. J Pharm Sci 97:2948-2983.
15. Durán N, Marcato PD, de Souza GD, Alves OL, Esposito E. 2007. Antibacterial effect of silver nanoparticles produced by fungal process on textile fabrics and their efluent treatment. J Biomed Nanotechnol 3:203-208. (Pubitemid 351877171)
16. Nair LS, Laurencin CT. 2007. Biodegradable polymers as biomaterials. Progr Polym Sci 32:762-798.
17. Grynberg NF, Echevarria A, Lima JE, Pamplona SSR, Pinto AC, Maciel MAM. 1999. Anti-tumor activity of two 19-nor-clerodane diterpenes, transdehydrocrotonin and trans-crotonin, from Croton cajucara. Planta Med 65:687-689.
18. Melo PS, Justo GZ, Durán N, Haun M. 2004. Natural killer cell activity and anti-tumour effects of dehydrocrotonin and its synthetic derivatives. Eur J Pharmacol 487:47-54. (Pubitemid 38372183)
19. Rodriguez JA, Hiruma-Lima CA, Brito ARMS. 2004. Antiulcer activity and subacute toxicity of trans-dehydrocrotonin from Croton cajucara. Hum Exp Toxicol 23:455-461.
20. Silva RM, Oliveira FA, Cunha KMA, Maia JL, Maciel MAM, Pinto AC, Nascimento NRF, Santos FA, Rao VSN. Cardiovascular effects of trans-dehydrocrotonin, a diterpene from Croton cajucara in rats. Vasc Pharmacol 43:11-18.
21. Anazetti MC, Melo PS, Durán N, Haun M. 2004. Dehydrocrotonin and its derivative, dimethylamide-crotonin induce apoptosis with lipid peroxidation and activation of caspases-2, -6 and -9 in human leukemic cells HL60. Toxicology 203:123-137. (Pubitemid 39206297)
22. Souza-Brito ARM, Rodriguez JA, Hiruma-Lima CA, Haun M, Nunes DS. 1998. Anti-ulcerogenic activity of trans-dehydrocrotonin from Croton cajucara Benth. Planta Med 64:126-129. (Pubitemid 28153270)
23. Yan Y, Bornscheuer UT, Schimid RD. 1999. Lipase-catalyzed synthesis of vitamin C fatty acid esters. Biotechnol Lett 21:1051-1054. (Pubitemid 30045731)
24. Cui F, Shi K, Zhang L, Tao A, Kawashima Y. 2006. Biodegradable nanoparticles loaded with insulin-phospholipid complex for oral delivery: Preparation, in vitro characterization and in vivo evaluation. J Control Release 114:242-250. (Pubitemid 44291843)
25. Houmeau C, Girardin M, Rovel B, Miclo A. 1998. Enzymatic synthesis of fatty acid ascorbyl esters. J Mol Catal B: Enzym 5:19-23. (Pubitemid 28429169)
26. Gryparis EC, Mattheolabakis G, Bikiaris D, Avgoustakis K. 2007. Effect of conditions of preparation on the size and encapsulation properties of PLGA-mPEG nanoparticles of cisplatin. Drug Deliv 14:371-380. (Pubitemid 47265821)
27. Anazetti MC, Melo PS, Durán N, Haun M. 2003. Comparative cytotoxicity of dimethylamide-crotonin in the promyelocytic leukemia cell line (HL60) and human peripheral blood mononuclear cells. Toxicology 188:261-274. (Pubitemid 36588904)
28. Freire ACG, Melo PS, Aoyama H, Haun M, Durán N, Ferreira CV. 2003. Cytotoxicity effect of lactone from Croton cajucara on human promyelocytic leukemia cells. Planta Med 69:67-69.
29. Freire ACG, Assis CF, Frick AO, Melo PS, Haun M, Aoyama H, Durán N, Sauer MM, Kallás EG, Ferreira CV. 2003. Influence of protein phosphatase inhibitors on the HL-60 cells death by dehydrocrotonin. Leuk Res 65:687-689. (Pubitemid 36683330)
30. Stroh C, Schulze-Osthoff K. 1998. Death by a thousand cuts: An ever increasing list of caspase substrates. Cell Death Differ 5:997-1000. (Pubitemid 29008212)
31. Mosqueira VC, Legrand P, Pinto-Alphandary H, Puisieux F, Barratt F. 2000. Poly(D,L-lactide) nanocapsules prepared by a solvent displacement process: Influence of the composition on physicochemical and structural properties. J Pharm Sci 89:614-626. (Pubitemid 30692832)
32. Kubo I, Asaka Y, Shibata K. 1991. Insect growth inhibitory nor-diterpenes, cis-dehydrocrotonin and trans-dehydrocrotonin, from Croton cajucara. Phytochemistry 30:2545-2546.
33. Chen Q, Espey MG, Sun AY, Lee JH, Krishna MC, Shacter E, Choyke PL, Pooput C, Kirk KL, Buettner GR, Levine M. 2007. Ascorbate in pharmacologic concentrations selectively generates ascorbate radical and hydrogen peroxide in extracellular fluid in vivo. Proc Natl Acad Sci USA 104:8749-8754. (Pubitemid 47175383)
34. 2, in human leukemia cells. Biochem Pharmacol 63:1325-1335.
35. Fransson LA, Mani K. 2007. Novel aspects of vitamin C: How important is glypican-1 recycling? Trends Mol Med 13:143-149.
36. Czech MP, Jr., Lawrence JC, Lynn WC. 1974. Evidence for the involvement of sulfhydryl oxidation in the regulation of fat cell hexose transport by insulin. Proc Natl Acad Sci USA 71:4173-4177.
37. Sagun KC, Cárcamo JM, Golde DW. 2005. Vitamin C enters mitochondria via facilitative glucose transporter 1 (Glut1) and confers mitochondrial protections against oxidative injury. FASEB J 19:1657-1667.
38. Xie SQ, Liu GC, Ma YF, Cheng PF, Wu YL, Wang MW, Ji BS, Zhao J, Wang CJ. 2008. Synergistic antitumor effects of anthracenylmethyl homospermidine and alpha-difluoromethylornithine on promyelocitic leukemia HL60 cells. Toxicol Vitr 22:352-358. (Pubitemid 351163540)
39. Dzietko M, Boos V, Sifringer M, Polley O, Gerstner B, Genz K, Endesfelder S, Borner C, Jacotot E, Chauvier D, Obladen M, Buhrer C, Felderhoff-Mueser U. 2008. A critical role for Fas/CD-95 dependent signaling pathways in the pathogenesis of hyperoxia-induced brain injury. Ann Neurol 64:664-673.